Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.25 USD
Change Today +0.15 / 2.11%
Volume 111.4K
CCXI On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas J. Schall Ph.D.

Founder, Chairman, Chief Executive Officer and President, ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
55$2,635,935
As of Fiscal Year 2014

Background*

Dr. Thomas J. Schall, Ph.D. founded ChemoCentryx Inc. in November 1996 and has been its Chief Executive Officer and President since November 1996. Dr. Schall focuses on the discovery and development of chemokine-based therapeutics widely regarded as a Leader in chemokine research, his laboratories have been responsible for the discovery or co-discovery of almost one-third of all known chemokine receptors. From December 1993 to November 1996, he worked at the DNAX ResearchInstitute, ...

Read Full Background

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

1996-Present
Founder, Chairman, Chief Executive Officer and President

Education*

PhD
Stanford University
BS
Northern Illinois University

Other Affiliations*

Annual Compensation*

Salary$550,000
Total Annual Compensation$550,000

Stock Options*

All Other Compensation$1,290
Exercisable Options1,465,156
Unexercisable Options719,098
Total Number of Options2,184,254

Total Compensation*

Total Annual Cash Compensation$798,790
Total Short Term Compensation$550,000
Other Long Term Compensation$1,290
Total Calculated Compensation$2,635,935
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $7.25 USD +0.15

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.